|
|
||||||||
1 Obesity Research Center, St. Luke's-Roosevelt Hospital, New York 10025; and 2 Department of Radiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032
Magnetic resonance imaging (MRI) has the ability to discriminate between various soft tissues in vivo. Whole body, specific organ, total adipose tissue (TAT), intra-abdominal adipose tissue (IAAT), and skeletal muscle (SM) weights determined by MRI were compared with weights determined by dissection and chemical analysis in two studies with male Sprague-Dawley rats. A 4.2-T MRI machine acquired high-resolution, in vivo, longitudinal whole body images of rats as they developed obesity or aged. Weights of the whole body and specific tissues were determined using computer image analysis software, including semiautomatic segmentation algorithms for volume calculations. High correlations were found for body weight (r = 0.98), TAT (r = 0.99), and IAAT (r = 0.98) between MRI and dissection and chemical analyses. MRI estimated the weight of the brain, kidneys, and spleen with high accuracy (r > 0.9), but overestimated IAAT, SM, and liver volumes. No differences were detected in organ weights using MRI and dissection measurements. Longitudinal MRI measurements made during the development of obesity and aging accurately represented changes in organ and tissue mass.
longitudinal body composition; in vivo; obesity; high-fat diet; small animal
This article has been cited by other articles:
![]() |
Z. Chen, Z. Wang, T. Lohman, S. B. Heymsfield, E. Outwater, J. S. Nicholas, T. Bassford, A. LaCroix, D. Sherrill, M. Punyanitya, et al. Dual-Energy X-Ray Absorptiometry Is a Valid Tool for Assessing Skeletal Muscle Mass in Older Women J. Nutr., December 1, 2007; 137(12): 2775 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Y. Ruan, D. Gallagher, T. Harris, J. Albu, S. Heymsfield, P. Kuznia, and S. Heshka Estimating whole body intermuscular adipose tissue from single cross-sectional magnetic resonance images J Appl Physiol, February 1, 2007; 102(2): 748 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Garcia, I. Wernstedt, A. Berndtsson, M. Enge, M. Bell, O. Hultgren, M. Horn, B. Ahren, S. Enerback, C. Ohlsson, et al. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes, May 1, 2006; 55(5): 1205 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xie, C. Audette, M. Hoffee, J. M. Lambert, and W. A. Blattler Pharmacokinetics and Biodistribution of the Antitumor Immunoconjugate, Cantuzumab Mertansine (huC242-DM1), and Its Two Components in Mice J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1073 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Cline, K. Johnson, W. Regittnig, P. Perret, E. Tozzo, L. Xiao, C. Damico, and G. I. Shulman Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats Diabetes, October 1, 2002; 51(10): 2903 - 2910. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bentley, M. C. Ortiz, E. L. Ritman, and J. C. Romero The use of microcomputed tomography to study microvasculature in small rodents Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1267 - R1279. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |